BRAF and metastatic malignant neoplasm in the lymph nodes: These authors reported 46% vs. 24% for peritoneal metastasis when comparing BRAF mutated vs. BRAF wild-type respectively, 53% vs. 38% for lymph nodes metastases, and 35% vs. 49% for lung metastasis [37].